antisense oligonucleotide-based therapeutics (Yarrow Biotechnology/ProQR Therapeutics)

N/A

Report date: 2025/01/26 17:59:46
NME

Base Information

Drug Nameantisense oligonucleotide-based therapeutics (Yarrow Biotechnology/ProQR Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProqr Therapeutics Nv
China Registration ClassN/A

Develop Information

Active CompaniesYarrow Biotechnology IncProqr Therapeutics Nv
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A